top of page

PIPELINE

Creating Transformative Solutions for Patients

제목 없음-3.png

ߊ ​PIPELINE

TRANSMAB® TECHNOLOGY

TARGET

INDICATION

DISCOVERY

PRE-CLINICAL

EARLY CLINICAL

LATE CLINICAL

PARTNERSHIP

그림3.png

TARGET

INDICATION

STATUS

PD-L1

Alzheimer's

Pre-Clinical

PD-L1

Alzheimer's

Undisclosed

Alzheimer's

Discovery

Undisclosed

Neurodegeneration

Discovery

Undisclosed

Alzheimer's

Undisclosed

Neurodegeneration

Internal

Internal

Undisclosed

bottom of page